Thomas H. Kean, Representative
sell disclosed on 18 Jun 2026 via House STOCK Act disclosures
- Transaction value
- 1.001 US$
- Copy Window
- Worth researching
- Data Confidence
- 93%
- Previous signal outcome
- 0.0%
Public company research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Company research history
Source-transparent disclosure history for this company, built from public CopyWindow signals and previous hypothetical outcomes.
Thomas H. Kean, Representative
sell disclosed on 18 Jun 2026 via House STOCK Act disclosures
Thomas H. Kean, Representative
buy disclosed on 18 Sept 2025 via House STOCK Act disclosures
Thomas H. Kean, Representative
buy disclosed on 20 Aug 2025 via House STOCK Act disclosures
Josh Gottheimer, Representative
sell disclosed on 16 Jun 2022 via House STOCK Act disclosures
Josh Gottheimer, Representative
sell disclosed on 16 Jun 2022 via House STOCK Act disclosures
Josh Gottheimer, Representative
sell disclosed on 16 Jun 2022 via House STOCK Act disclosures
Josh Gottheimer, Representative
sell disclosed on 16 Jun 2022 via House STOCK Act disclosures